Determinants of COVID-19 Disease Severity-Lessons from Primary and Secondary Immune Disorders including Cancer.

Solimando, Antonio G; Bittrich, Max; Shahini, Endrit; Albanese, Federica; Fritz, Georg; Krebs, Markus

Solimando, Antonio G; Bittrich, Max; Shahini, Endrit; Albanese, Federica; Fritz, Georg; Krebs, Markus.

Afiliação

Solimando AG; Guido Baccelli Unit of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area-(DiMePRe-J), Aldo Moro Bari University, 70100 Bari, Italy.
Bittrich M; Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany.
Shahini E; Gastroenterology Unit, National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy.
Albanese F; Guido Baccelli Unit of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area-(DiMePRe-J), Aldo Moro Bari University, 70100 Bari, Italy.
Fritz G; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy at the Immanuel Klinikum Bernau, Heart Center Brandenburg, 16321 Bernau, Germany.
Krebs M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany.

Int J Mol Sci ; 24(10)2023 May 14.

Article em En | MEDLINE | ID: mdl-37240091

Assuntos

COVID-19; Doenças do Sistema Imunitário; Neoplasias; Humanos; Masculino; SARS-CoV-2; Pandemias; Neoplasias/epidemiologia; Gravidade do Paciente

Palavras-chave

COVID-19; SARS-CoV-2; cancer; disorder of immunity

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 / Doenças do Sistema Imunitário / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google